HOXC8 and intrahepatic cholangiocarcinoma: It has the potential to efficiently facilitate the proliferation, metastasis and immune evasion of ICC by regulating the expression of HOXC8 and PD-L1, indicating its significance as a crucial therapeutic target for ICC.